INCRESYNC 25mg/15mg Price

Overview

Welcome to Dwaey, specifically on INCRESYNC 25mg/15mg page.
This medicine contains an important and useful components, as it consists of
Alogliptin (as benzoate), Pioglitazone (as HCl)is available in the market in concentration

Name

Chlorpromazine Hydrochloride

Precaution

Chlorpromazine Hydrochloride is an antipsychotic drug used to treat a variety of psychiatric and behavioral disorders. However, it must be used cautiously in certain populations due to potential risks: - **Pregnancy and breastfeeding**: - **Pregnancy**: Chlorpromazine is categorized as a Category C drug by the FDA, meaning it should only be used during pregnancy if the potential benefits outweigh the risks. It can cross the placenta, and its use during pregnancy, especially in the first trimester, may be associated with potential risks to the fetus, including neonatal withdrawal symptoms. - **Breastfeeding**: Chlorpromazine is excreted in breast milk, and its use during lactation should be avoided unless necessary. It may cause sedation and extrapyramidal symptoms in a nursing infant. - **Pre-existing conditions**: - **Cardiovascular diseases**: Chlorpromazine can cause orthostatic hypotension (a drop in blood pressure when standing up), which can be dangerous for patients with heart conditions. Caution should be exercised in patients with a history of cardiovascular disease, including heart failure, arrhythmias, or recent myocardial infarction. - **Liver dysfunction**: Patients with hepatic impairment may experience prolonged drug half-life and accumulation of the drug in the body, increasing the risk of toxicity. Dose adjustments are typically required for these individuals. - **CNS disorders**: Chlorpromazine can lower the seizure threshold, which may be problematic for patients with a history of seizures or epilepsy. Regular monitoring is recommended in such cases. - **Tardive dyskinesia**: Long-term use of chlorpromazine can lead to tardive dyskinesia, a potentially irreversible condition characterized by involuntary, repetitive movements. It is particularly common in older adults, especially those treated with high doses. - **Elderly population**: Older adults are more susceptible to the side effects of chlorpromazine, such as sedation, hypotension, and anticholinergic effects like dry mouth and constipation. Lower doses and careful monitoring are recommended for elderly patients.

Indication

Chlorpromazine Hydrochloride is primarily used to treat a wide range of psychiatric and psychological disorders. Its main indications include: - **Schizophrenia**: Chlorpromazine is used to treat the positive and negative symptoms of schizophrenia, such as delusions, hallucinations, and disorganized behavior. It is often used as a first-line treatment for acute psychotic episodes. - **Bipolar disorder**: Chlorpromazine can be used in the acute treatment of manic episodes in bipolar disorder, providing symptomatic relief from agitation, aggression, and severe mood swings. - **Severe behavioral disturbances**: Chlorpromazine is also used to manage severe anxiety, agitation, and behavior issues in certain patients, particularly those with intellectual disabilities or dementia. - **Nausea and vomiting**: Due to its antiemetic properties, chlorpromazine is used off-label to treat nausea and vomiting associated with various conditions, including chemotherapy-induced nausea. - **Off-label uses**: Chlorpromazine is sometimes used to manage symptoms of other psychiatric disorders, including severe anxiety and short-term management of agitation in hospitalized patients.

Contra indication

Chlorpromazine Hydrochloride should not be used in the following conditions: - **Hypersensitivity**: Any known allergy to chlorpromazine or other phenothiazines contraindicates its use. Severe allergic reactions, including anaphylaxis, can occur. - **Comatose patients or those with CNS depression**: Chlorpromazine can exacerbate symptoms in patients who are already comatose or deeply sedated, as it is a CNS depressant. - **Bone marrow suppression**: Chlorpromazine is contraindicated in patients with a history of bone marrow suppression or blood dyscrasias (e.g., agranulocytosis, leukopenia), as it may exacerbate these conditions. - **Severe liver disease**: Patients with severe hepatic impairment may not be able to metabolize chlorpromazine properly, which can lead to drug accumulation and toxicity. It is contraindicated in these patients. - **Parkinson's disease**: Due to its dopamine antagonist effects, chlorpromazine can exacerbate the symptoms of Parkinson’s disease, including rigidity and bradykinesia, and is therefore contraindicated in such patients. - **Pheochromocytoma**: Chlorpromazine should not be used in patients with pheochromocytoma, a tumor of the adrenal glands that can lead to excessive catecholamine release, as it may cause severe hypertension and arrhythmias.

Side Effect

Chlorpromazine has a broad range of potential side effects, which can vary from mild to severe: - **Common side effects**: - **Sedation**: Drowsiness or fatigue is one of the most frequent side effects, especially during the initial stages of treatment. This effect can interfere with daily activities. - **Hypotension**: Chlorpromazine can cause orthostatic hypotension, leading to dizziness, especially when standing up. Patients are advised to rise slowly from sitting or lying positions. - **Anticholinergic effects**: These can include dry mouth, constipation, blurred vision, urinary retention, and tachycardia. - **Less common side effects**: - **Extrapyramidal symptoms (EPS)**: These include symptoms such as tremors, rigidity, bradykinesia, and tardive dyskinesia, which can occur with long-term use. These symptoms are often managed with anticholinergic medications. - **Weight gain**: Some patients may experience significant weight gain, which can increase the risk of metabolic disorders such as diabetes and hyperlipidemia. - **Serious side effects**: - **Tardive dyskinesia**: This is a serious and potentially irreversible condition involving involuntary, repetitive movements of the face and body. It is more likely with long-term use of chlorpromazine. - **Neuroleptic malignant syndrome (NMS)**: A rare but life-threatening condition characterized by fever, altered mental status, muscle rigidity, and autonomic dysfunction. Immediate medical intervention is required. - **Agranulocytosis**: A serious reduction in white blood cells, which can lead to severe infections. Regular blood tests should be conducted to monitor for this condition. - **Severe hypotension and cardiac arrhythmias**: In rare cases, chlorpromazine can cause severe hypotension, leading to syncope or arrhythmias, particularly when taken with other drugs that affect the cardiovascular system.

Pregnancy Category ID

3

Mode of Action

Chlorpromazine is a **typical antipsychotic** drug that exerts its therapeutic effects primarily through the **dopamine receptor antagonism** in the brain: - **Dopamine receptor blockade**: Chlorpromazine works by blocking D2 dopamine receptors in the brain, which is thought to be responsible for the reduction in psychotic symptoms. This is particularly useful in treating schizophrenia and other psychotic disorders. - **Other neurotransmitter effects**: In addition to dopamine, chlorpromazine also affects other neurotransmitters such as serotonin, histamine, and norepinephrine, contributing to its sedative, antiemetic, and antihistaminic effects. - **Pharmacodynamics**: Chlorpromazine’s antagonism of dopamine receptors in the limbic system and other areas of the brain leads to its antipsychotic and mood-stabilizing effects. However, the same action can also result in unwanted side effects like extrapyramidal symptoms and tardive dyskinesia.

Interaction

Chlorpromazine can interact with a variety of drugs, potentially leading to significant clinical implications: - **Central nervous system (CNS) depressants**: Chlorpromazine can enhance the sedative effects of other CNS depressants, such as benzodiazepines, alcohol, and barbiturates. This combination can increase sedation, dizziness, and the risk of respiratory depression, and should be avoided. - **Antihypertensive agents**: Chlorpromazine can potentiate the effects of antihypertensive medications, leading to an increased risk of hypotension, especially when taken with drugs such as ACE inhibitors, diuretics, or beta-blockers. Blood pressure should be monitored regularly. - **Levodopa**: Levodopa, used in the treatment of Parkinson's disease, can have reduced efficacy when taken with chlorpromazine due to the dopamine antagonism properties of the drug. This interaction can worsen Parkinsonian symptoms. - **Anticholinergic drugs**: Concurrent use of chlorpromazine with other anticholinergic medications (e.g., atropine, antihistamines) can increase the risk of anticholinergic side effects like dry mouth, constipation, urinary retention, and blurred vision. - **QT-prolonging drugs**: Chlorpromazine can prolong the QT interval, which may increase the risk of arrhythmias, particularly when used with other medications that have similar effects (e.g., certain antiarrhythmic agents, antibiotics like macrolides, or antipsychotics).

Pregnancy Category Note

Information not available

Adult Dose

The typical starting dose for Chlorpromazine Hydrochloride in adults varies depending on the condition being treated: - **Schizophrenia**: The usual starting dose is 25–50 mg two or three times daily, which can be gradually increased up to 400–800 mg per day, depending on response and tolerability. - **Bipolar disorder**: Chlorpromazine is used in acute manic episodes, typically starting at 25 mg two or three times a day, with gradual increases based on clinical response. - **Nausea/vomiting**: For the management of nausea and vomiting, the dose may start at 25 mg, taken every 4–6 hours as needed. Doses above 800 mg per day are typically reserved for severe cases, and the medication should be adjusted based on therapeutic response and side effect profile.

Child Dose

The use of Chlorpromazine in children is generally limited to specific conditions and requires careful monitoring: - **Children with psychosis or severe behavioral disturbances**: The starting dose is typically 0.5–1 mg/kg/day, divided into 2–3 doses. The dose can be gradually increased based on clinical response and tolerance, up to a maximum of 3 mg/kg/day. - **Off-label use for nausea**: For younger children, lower doses are recommended, typically starting at 0.1–0.25 mg/kg, and adjusted as needed. Chlorpromazine use in children should be closely supervised due to the risk of significant side effects, such as sedation and extrapyramidal symptoms.

Renal Dose

In patients with **renal impairment**, the dose of Chlorpromazine may need to be reduced, as renal dysfunction can impair drug clearance, leading to increased risk of toxicity. Adjustments are typically made on a case-by-case basis depending on the severity of renal dysfunction. - **Mild renal impairment**: Generally, no dose adjustment is required, but close monitoring for side effects is recommended. - **Moderate to severe renal impairment**: Dose reductions are necessary. Close monitoring of therapeutic levels and side effects should be implemented.

Administration

Information not available